- 2022.06.02Information
【Overseas Event】EME will join Bio international Convention 2022
- 2022.04.21Information
【Overseas Event】EME will attend 18th Annual PEGS BOSTON Conference & Expo
- 2022.03.03Press Release
EME PUBLISHES NOVEL HUMANIZED SYNTHETIC VHH LIBRARY “PharmaLogical® Library” FOR THERAPEUTIC ON ANTIBODIES JORNAL.
- 2022.01.17Press Release
Successful Treatment for Coronavirus Disease 2019 in Hamster Models: A Significant Advancement for Clinical Use of VHH Antibodies Administered Nasally
- 2021.12.06Information
【Event】EME will Exhibit at PharmaLab Expo 2021
- 2021.10.26Press Release
EME Announces Research Agreement with Kyowa Kirin on VHH Antibody
- 2021.10.12Press Release
EME Announces Collaboration Agreement on Development of VHH Antibody
- 2021.10.06Information
【BioJapan Simultaneous Event】 EME will Exhibit at Japan Healthcare Venture Summit (JHVS) 2021
- 2021.09.28Press Release
EME Announces Collaboration Agreement with JCR on Drug Discovery and Development for VHHs
- 2020.12.23Press Release
Series A financing of 570 million yen procured by Epsilon Molecular Engineering: A next-generation medium sized molecular biotechnology-based drug discovery firm